
Buttgereit discussed notable findings from the SELECT-GCA trial

Professor of Rheumatology and Deputy Head of the Department of Rheumatology and Clinical Immunology, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin

Buttgereit discussed notable findings from the SELECT-GCA trial

New findings highlight upadacitinib's effectiveness in treating giant cell arteritis, showcasing lower infection rates and improved glucocorticoid tapering strategies.

Published: July 9th 2025 | Updated:

Published: August 8th 2025 | Updated: